The Transaxillary Access for Minimally Invasive Valve Surgery is Safe and Effective in Selected Patients with Native Valve Endocarditis
The Thoracic and Cardiovascular Surgeon · 01.01.2026 · 74 (S 01 S 01) · S1-S70
DOI: 10.1055/s-0046-1817276 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.01.2026. Verfasst von A. Petrov und 8 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window)
Background
Minimally invasive techniques are increasingly applied in the treatment of infective endocarditis. Transaxillary access represents a novel surgical approach, but evidence regarding its safety and efficacy remains limited. We evaluated outcomes of patients undergoing transaxillary surgery for native aortic and mitral valve endocarditis compared with a conventional sternotomy cohort.
Methods
Between 2021 and 2024, all consecutive patients undergoing surgery for infective endocarditis at our institution were screened. Exclusion criteria were extensive abscess formation, redo procedures, right-sided endocarditis, and concomitant bypass surgery. Of 316 patients, 179 (56.7%) met the inclusion criteria and were stratified into a transaxillary ( n = 81) and a sternotomy group ( n = 98).
Results
Patient age was 63.0 vs. 64.5 years, p = 0.49 in the transaxillary and sternotomy cohorts, and gender distribution was similar. Transaxillary patients had lower risk scores (EuroSCORE II 2.98% vs. 6.24%, p < 0.001). Multivalve procedures were more frequent with sternotomy patients— n = 3 (3.7%) vs. n = 23 (23.5%), p < 0.001. Postoperative outcomes were comparable, except for shorter intensive care unit stay (2 vs. 4 days, p < 0.001), reduced ventilation time (6 vs. 12 hours, p < 0.001), and less frequent renal failure in the transaxillary cohort. Transaxillary patients had noninferior 30-day (92.6% vs. 78.4%) and long-term survival at 3 years (81.2% vs. 68.0%; p < 0.01). Rates of recurrent endocarditis did not differ— n = 5, 6.2% vs. n = 6, 6.1%, p = 1.00.
Conclusion
In selected patients, transaxillary minimally invasive surgery provides noninferior survival compared with sternotomy, without sacrificing procedural safety. A comprehensive diagnostic approach is essential to exclude patients who need extensive reconstructive surgery. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Petrov, A., Taghizadeh-Waghefi, A., Kolaschnik, M., Arzt, S., Alexiou, K., Tugtekin, S., Matschke, K., Kappert, U., & Wilbring, M. (2026). The Transaxillary Access for Minimally Invasive Valve Surgery is Safe and Effective in Selected Patients with Native Valve Endocarditis. The Thoracic and Cardiovascular Surgeon, 74(S 01 S 01), S1-S70. https://doi.org/10.1055/s-0046-1817276
Vancouver
Petrov A, Taghizadeh-Waghefi A, Kolaschnik M, Arzt S, Alexiou K, Tugtekin S, et al. The Transaxillary Access for Minimally Invasive Valve Surgery is Safe and Effective in Selected Patients with Native Valve Endocarditis. The Thoracic and Cardiovascular Surgeon. 2026;74(S 01 S 01):S1-S70. doi:10.1055/s-0046-1817276
BibTeX
@article{Petrov2026,
author = {Petrov, A. and Taghizadeh-Waghefi, A. and Kolaschnik, M. and Arzt, S. and Alexiou, K. and Tugtekin, SM. and Matschke, K. and Kappert, U. and Wilbring, M.},
title = {The Transaxillary Access for Minimally Invasive Valve Surgery is Safe and Effective in Selected Patients with Native Valve Endocarditis},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 01 S 01},
pages = {S1--S70},
doi = {10.1055/s-0046-1817276}
}
EUVIMED